Navigation Links
Particle Sciences Develops Methods for Increasing Quality of Sintered Metal Products and for Coating Surfaces with Metal Oxide Films
Date:9/16/2008

BETHLEHEM, Pa., Sept. 16 /PRNewswire/ -- Particle Sciences, Inc. announces the issuing of its patent (US7,419,527) on a unique system for increasing the density of sintered metal products. The technology allows for the processing of powdered metals in a way that decreases needed injection forces, decreases lubricant requirements and results in structurally superior end-products. It is based on a proprietary coating applied to the powders prior to sintering. "This could both increase the quality of the finished product and substantially decrease the environmental impact of the manufacturing process," says Garry Gwozdz, Director of Formulation and one of the inventors at Particle Sciences. Particle Sciences is a CRO primarily focused on pharmaceutical applications. This technology is an offshoot of some of their nano-particle work involving a unique drug delivery approach. "This is pretty far from our core business so we intend to out-license the technology. It could dovetail nicely with an earlier technology we developed and patented (US6,045,650) involving the coating of surfaces with metal oxides, titanium dioxide for instance. The '527 provides for sintered metal products with improved physical characteristics and lowered carbon footprint. The '650 technology allows for the application of low cost carefully controlled, even printable, metal oxide surface coatings. Both of these technologies came out of our efforts in the pharmaceutical arena but clearly have broader applicability so we intend to partner with companies that can better take advantage of the opportunities," says Dr. Mark Mitchnick, CEO of Particle Sciences. For more information, visit http://www.particlesciences.com.

Particle Sciences is an integrated provider of drug development services. Particle Sciences focuses on emulsions, gels, particulates and drug/device combination products with additional specialized capabilities in topical and mucosal drug delivery. Through a full range of formulation, analytic, and manufacturing services, Particle Sciences provides pharmaceutical companies with a complete and seamless development solution that minimizes the time and risk between discovery and the clinic. The company was founded in 1991 and is headquartered in Bethlehem, Pennsylvania.

Contact:

Maureen Cochran

mcochran@particlesciences.com


'/>"/>
SOURCE Particle Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Particle Sciences Develops Zero-Order-Release Combination Device Technology
2. New disease-fighting nanoparticles look like miniature pastries
3. Nanoparticles + light = dead tumor cells
4. Using magenetic nanoparticles to combat cancer
5. Nanoparticle Stops Cancer From Spreading
6. Waves, particles and medicine in Houston
7. Smart bomb nanoparticle strategy impacts metastasis
8. MAP Pharmaceuticals Acquires Proprietary Drug Particle Formulation Technology From Eiffel/Telesso Technologies Limited
9. Nanoparticles aid bone growth
10. Magnetic nanoparticles: Suitable for cancer therapy?
11. Brown chemists create cancer-detecting nanoparticles
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief ... a minimum wage raise to $12 an hour by 2020 and then adjusting it yearly ... lost value of the minimum wage, assure the wage floor does not erode again, and ...
(Date:6/24/2016)... Georgia (PRWEB) , ... June 24, 2016 , ... ... awards today at the Clinical Decision Making in Emergency Medicine conference in Ponte ... have authored journal articles published in Emergency Medicine Practice and Pediatric ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Investment Group (TGIG), has initiated cultivation and processing operations at its production facility, ... Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of proactive ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone Partners ... extensive sequencing and genomics experience, as Vice President of North American Capital Sales at ... responsible for leading the sales team in the commercialization of the HTG EdgeSeq system ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... human induced pluripotent stem (iPS) cells and other difficult to transfect cells, announces ... Medium. The PluriQ™ G9™ Gene Editing System is a complete system ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... 2022" report to their offering. ... with kidney failure, it replaces the function of kidneys by ... and thus the treatment helps to keep the patient body,s ... Increasing number of ESRD patients & substantial healthcare ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
Breaking Medicine Technology: